HK1029343A1 - Process for making diaryl pyridines useful as cox-2 inhibitors - Google Patents

Process for making diaryl pyridines useful as cox-2 inhibitors

Info

Publication number
HK1029343A1
HK1029343A1 HK01100155A HK01100155A HK1029343A1 HK 1029343 A1 HK1029343 A1 HK 1029343A1 HK 01100155 A HK01100155 A HK 01100155A HK 01100155 A HK01100155 A HK 01100155A HK 1029343 A1 HK1029343 A1 HK 1029343A1
Authority
HK
Hong Kong
Prior art keywords
cox
inhibitors
pyridines useful
making diaryl
diaryl pyridines
Prior art date
Application number
HK01100155A
Other languages
English (en)
Inventor
Ian W Davies
Michel Journet
Philip J Pye
Linda Gerena
Robert D Larsen
Kai Rossen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806419.9A external-priority patent/GB9806419D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HK1029343A1 publication Critical patent/HK1029343A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK01100155A 1997-09-25 2001-01-06 Process for making diaryl pyridines useful as cox-2 inhibitors HK1029343A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6068097P 1997-09-25 1997-09-25
GBGB9806419.9A GB9806419D0 (en) 1998-03-25 1998-03-25 Process for making diaryl pyridines useful as cox-2 inhibitors
PCT/US1998/019788 WO1999015503A2 (en) 1997-09-25 1998-09-22 Process for making diaryl pyridines useful as cox-2 inhibitors

Publications (1)

Publication Number Publication Date
HK1029343A1 true HK1029343A1 (en) 2001-03-30

Family

ID=26313354

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100155A HK1029343A1 (en) 1997-09-25 2001-01-06 Process for making diaryl pyridines useful as cox-2 inhibitors

Country Status (15)

Country Link
EP (1) EP1023266B1 (ja)
JP (2) JP3325263B2 (ja)
CN (1) CN1134415C (ja)
AR (1) AR015938A1 (ja)
AT (1) ATE230726T1 (ja)
AU (1) AU9500298A (ja)
BR (1) BR9812837B1 (ja)
CZ (1) CZ298850B6 (ja)
DE (1) DE69810652T2 (ja)
DK (1) DK1023266T3 (ja)
EA (1) EA002427B1 (ja)
ES (1) ES2189251T3 (ja)
HK (1) HK1029343A1 (ja)
SK (1) SK283811B6 (ja)
WO (1) WO1999015503A2 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE253559T1 (de) * 1999-01-14 2003-11-15 Lonza Ag Verfahren zur herstellung von 1-(6-methylpyridin- 3-yl)-2- 4-(methylsulfonyl phenyl)ethanon
MXPA01007169A (es) 1999-01-14 2003-06-06 Lonza Ag 1-(6-metilpiridin-3-il)-2-(4-(metilsulfonil)fenil)etanona y metodo para su elaboracion.
JP3032980B1 (ja) 1999-06-14 2000-04-17 三協化学株式会社 2―ピリジルピリジン誘導体の製造方法
JP4773013B2 (ja) * 1999-07-27 2011-09-14 ロンザ アーゲー 1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンの製造方法
US6566527B1 (en) 1999-07-27 2003-05-20 Merck & Co., Inc. Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-methylsulphonyl)-phenyl]ethanone
JP2001115963A (ja) 1999-10-13 2001-04-27 Daikin Ind Ltd 圧縮機
IT1315244B1 (it) * 1999-10-15 2003-02-03 Zambon Spa Processo per la preparazione di intermedi utili nella sintesi didiarilpiridine
IT1315243B1 (it) * 1999-10-15 2003-02-03 Zambon Spa Processo di ossidazione per la preparazione di intermedi utili nellasintesi di diarilpiridine
JP2001261646A (ja) * 2000-03-17 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造法
JP2001261647A (ja) * 2000-03-22 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造方法
DK1303265T3 (da) 2000-07-20 2007-11-12 Lauras As Anvendelse af COX-2-inhibitorer, som immunostimulerende midler ved behandling af HIV eller AIDS
ITMI20012692A1 (it) * 2001-12-19 2003-06-19 Zambon Spa Processo di ossidazione per la preparazione di intermedi utili nella sintesi di diarilpiridine
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
EP2582690B1 (en) 2010-06-16 2018-07-25 Glenmark Generics Limited Process for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates
MY163379A (en) * 2010-11-15 2017-09-15 Virdev Intermediates Pvt Ltd A process for cyclooxygenase-2 selective inhibitor
ITMI20110362A1 (it) 2011-03-09 2012-09-10 F I S Fabbrica Italiana Sint P A Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
CN102276517B (zh) * 2011-06-29 2012-11-28 孙光辉 二芳基吡啶类药物的合成方法
ITMI20111455A1 (it) 2011-07-29 2013-01-30 Italiana Sint Spa Nuovo procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
WO2013065064A1 (en) * 2011-10-31 2013-05-10 Sequent Scientific Limited A process for preparation of l-(6-methylpyridin-3-yl)-2-[4-(meth.ylsulfonyi)phenyl]ethanone field of invention
CN103204803A (zh) 2012-01-13 2013-07-17 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 用于合成依托考昔的方法
ITMI20121947A1 (it) * 2012-11-15 2014-05-16 Erregierre Spa Processo di sintesi di un intermedio nella produzione di etoricoxib
ITVI20130014A1 (it) 2013-01-22 2014-07-23 Italiana Sint Spa Procedimento molto efficiente per preparare un intermedio di etoricoxib
CN104418799A (zh) * 2013-09-03 2015-03-18 天津药物研究院 一种依托考昔的晶型及其制备方法和应用
WO2015036550A1 (en) * 2013-09-13 2015-03-19 Synthon B.V. Process for making etoricoxib
CN104529798B (zh) * 2014-12-10 2016-03-30 齐鲁天和惠世制药有限公司 一种依托考昔中间体3-氨基-2-氯丙烯醛的制备方法
CH712810B1 (de) * 2015-07-21 2020-07-15 Sumitomo Chemical Co Verfahren zur Herstellung einer 4-(Trifluormethylsulfonyl)phenol-Verbindung.
CN108689917A (zh) * 2017-04-08 2018-10-23 深圳市华先医药科技有限公司 一种依托考昔中间体连续流生产工艺
CN109810052B (zh) * 2017-11-20 2020-06-23 新发药业有限公司 一种高选择性的阿帕替尼的简便制备方法
CN112300061B (zh) * 2020-10-06 2022-02-18 大连理工大学 一种含氮杂环二芳酮化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277103A (en) * 1961-06-29 1966-10-04 Du Pont beta-amino-alpha-cyanoacroleins and their preparation
US4242515A (en) * 1979-03-28 1980-12-30 American Cyanamid Company Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines
CH660733A5 (de) * 1981-09-29 1987-06-15 Lonza Ag Verfahren zur herstellung von 3-picolin.
DE3634259A1 (de) * 1986-10-08 1988-04-21 Basf Ag Verfahren zur herstellung von substituierten pyridinen
EP0548559A1 (en) * 1991-12-27 1993-06-30 American Cyanamid Company Process for the preparation of dialkyl pyridine -2,3-dicarboxylates and derivatives thereof from dialkyl dichloromaleate
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation

Also Published As

Publication number Publication date
JP2001517654A (ja) 2001-10-09
SK4222000A3 (en) 2000-10-09
EA002427B1 (ru) 2002-04-25
DE69810652T2 (de) 2003-10-09
EP1023266A2 (en) 2000-08-02
CZ20001088A3 (cs) 2000-09-13
JP3325263B2 (ja) 2002-09-17
DE69810652D1 (de) 2003-02-13
EP1023266B1 (en) 2003-01-08
CN1134415C (zh) 2004-01-14
SK283811B6 (sk) 2004-02-03
JP4157325B2 (ja) 2008-10-01
BR9812837B1 (pt) 2010-08-24
ES2189251T3 (es) 2003-07-01
EA200000358A1 (ru) 2000-10-30
WO1999015503A2 (en) 1999-04-01
WO1999015503A3 (en) 1999-05-20
BR9812837A (pt) 2000-08-08
ATE230726T1 (de) 2003-01-15
DK1023266T3 (da) 2003-02-24
JP2003026687A (ja) 2003-01-29
AR015938A1 (es) 2001-05-30
AU9500298A (en) 1999-04-12
CZ298850B6 (cs) 2008-02-27
CN1278795A (zh) 2001-01-03

Similar Documents

Publication Publication Date Title
HK1029343A1 (en) Process for making diaryl pyridines useful as cox-2 inhibitors
PL344108A1 (en) Process for synthesizing cox-2 inhibitors
ZA981843B (en) Method for providing enhanced photosynthesis
PL345590A1 (en) Method for phosphatizing, rerinsing and cathodic electro-dipcoating
GB9819417D0 (en) Reaction method
GB2326898B (en) One-trip window-milling method
HUP0003155A3 (en) Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
AP9701147A0 (en) Process for substituted pyridines
GB9725898D0 (en) Process for treating metal surfaces
IL134991A0 (en) Method for the synthesis of quinoline derivatives
IL131772A0 (en) Improved method for producing thiazolidinediones
HU9900194D0 (en) Process for the preparation of pyridine dicarboxylate-derivatives
HU9902691D0 (en) Process for re-esterification of alfa-keto-carboxylic-acid-esters
GB2332596A9 (en) Method for predicting interference
IL132360A0 (en) Chemical process for the reduction of 1-substituted-3-hydroxymethyl-4-(4-fluorophenyl) tetrahydropyridines
AU1576799A (en) Method for pickling steel products
HUP0102016A3 (en) Method for copperplating substrates
AU7820598A (en) Cembranoid inhibitors of nicotinic acetylcholine receptors
AU9593198A (en) Method for metallizing holes
GB9806419D0 (en) Process for making diaryl pyridines useful as cox-2 inhibitors
EP1120644A4 (en) CORROSION / ANTI-CORROSION ANALYSIS METHOD
AU7652798A (en) Method for continuous production of dihydroxydiphenylalkanes
GB9709686D0 (en) Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
GB9823420D0 (en) Process for making phenyl heterocylces useful as cox-2 inhibitors
IL128611A0 (en) Process for the preparation of substituted pyridines

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120922